Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Internal Medicine
•
Rheumatology
•
Rheumatoid Arthritis
•
General Rheumatology
•
Allergy & Immunology
•
Immunosuppression
•
Anaphylaxis
•
Allergy
•
Immunology
Are there any immunosuppressive agents that have been shown to have utility in concurrent idiopathic anaphylaxis?
Patient with seropositive RA, immunodeficiency, and idiopathic anaphylaxis.
Related Questions
Are there concerns with combining anti-IL5 biologics (mepolizumab or benralizumab) for severe asthma with other biologics for RA (e.g. TNFi)?
Would you use the pneumococcal conjugate-21 vaccine (Capvaxive) instead of the conjugate-20 (Prevnar-20) for routine vaccinations in immunosuppressed patients?
What is your approach to differentiating RA-ILD from medication toxicity (I.e. from methotrexate)?
Does the presence of calcified granulomas on chest imaging influence your choice of biologic for treatment of psoriatic arthritis (or rheumatoid arthritis)?
Do you perform genetic testing when patients have persistent hypogammaglobulinemia after rituximab therapy?
How do you approach use of DMARDs and/or biologics for inflammatory arthritis in patients with a history of seizure disorder on anti-epileptic medications?
Can Dupixent (dupliumab) be safely used in patients who are taking other biologics for rheumatic disease?
Do you routinely consider FDG PET/CT imaging for workup of fever of unknown origin?
How do you approach managing nausea and GI side effects when initiating methotrexate?
How do you approach management of adult patients with CVID and sarcoid-like syndrome?